Josef Pfeuffer

Josef Pfeuffer

Auto-generated profile, based on publicly available information

Josef Pfeuffer

Siemens Healthcare, MR Application Development, Erlangen, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2019 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
MHMelissa W. Haskell
Melissa W. Haskell
SCStephen F. Cauley
Stephen F. Cauley
BBBerkin Bilgic
Berkin Bilgic
JHJulian Hossbach
Julian Hossbach
DSDaniel N. Splitthoff
Daniel N. Splitthoff
LWLawrence L. Wald
Lawrence L. Wald

1 August 2019 in Radiology
Verified
Journal Article
Closed access
GKGregor Koerzdoerfer
Gregor Koerzdoerfer
RKRainer Kirsch
Rainer Kirsch
KLKecheng Liu
Kecheng Liu
JPJosef Pfeuffer
Josef Pfeuffer
BHBernhard Hensel
Bernhard Hensel
MNMathias Nittka
Mathias Nittka
Relaxation times in solid compartments of the human brain measured with fast imaging with steady-state free precession MR fingerprinting varied less than 8.0% (95% confidence intervals: −8.0%, 8.0%... Background Only sparse literature investigates the reproducibility and repeatability of relaxometry methods in MRI. However, statistical data on reproducibility and repeatability of any quantitativ...

1 January 2019 in NeuroImage: Clinical
Verified
Journal Article
Open access
PHPatrick W. Hales
Patrick W. Hales
FDFelice D'ARco
Felice D'ARco
JCJessica Cooper
Jessica Cooper
JPJosef Pfeuffer
Josef Pfeuffer
DHDarren Hargrave
Darren Hargrave
CCChris Clark
Chris Clark
Diffusion- and perfusion-weighted MRI are valuable tools for measuring the cellular and vascular properties of brain tumours. This has been well studied in adult patients, however, the biological features of childhood brain tumours are unique, and paediatric-focused studies are less common. We aimed to assess the diagnostic utility of apparent diffusion coefficient (ADC) values derived from diffusion-weighted imaging (DWI) and cerebral blood flow (CBF) values derived from arterial spin labelling (ASL) in paediatric brain tumours. We performed a meta-analysis of published studies reporting ADC and ASL-derived CBF values in paediatric brain tumours. Data were combined using a random effects model in order to define typical parameter ranges for different histological tumour subtypes and WHO grades. New data were also acquired in a 'validation cohort' at our institution, in which ADC and CBF values in treatment naïve paediatric brain tumour patients were measured, in order to test the validity of the findings from the literature in an un-seen cohort. ADC and CBF quantification was performed by two radiologists via manual placement of tumour regions of interest (ROIs), in addition to an automated approach to tumour ROI placement. A total of 14 studies met the inclusion criteria for the meta-analysis, constituting data acquired in 542 paediatric patients. Parameters of interest were based on measurements from ROIs placed within the tumour, including mean and minimum ADC values (ADCROI-mean, ADCROI-min) and the maximum CBF value normalised to grey matter (nCBFROI-max). After combination of the literature data, a number of histological tumour subtype groups showed significant differences in ADC values, which were confirmed, where possible, in our validation cohort of 32 patients. In both the meta-analysis and our cohort, diffuse midline glioma was found to be an outlier among high-grade tumour subtypes, with ADC and CBF values more similar to the low-grade tumours. After grouping patients by WHO grade, significant differences in grade groups were found in ADCROI-mean, ADCROI-min, and nCBFROI-max, in both the meta-analysis and our validation cohort. After excluding diffuse midline glioma, optimum thresholds (derived from ROC analysis) for separating low/high-grade tumours were 0.95 × 10-3 mm2/s (ADCROI-mean), 0.82 × 10-3 mm2/s (ADCROI-min) and 1.45 (nCBFROI-max). These thresholds were able to identify low/high-grade tumours with 96%, 83%, and 83% accuracy respectively in our validation cohort, and agreed well with the results from the meta-analysis. Diagnostic power was improved by combining ADC and CBF measurements from the same tumour, after which 100% of tumours in our cohort were correctly classified as either low- or high-grade (excluding diffuse midline glioma). ADC and CBF values are useful for differentiating certain histological subtypes, and separating low- and high-grade paediatric brain tumours. The threshold values presented here are in agreement with previously published studies, as well as a new patient cohort. If ADC and CBF values acquired in the same tumour are combined, the diagnostic accuracy is optimised.

1 September 2017 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
CCChristopher C. Cline
Christopher C. Cline
XCXiao Chen
Xiao Chen
BMBoris Mailhe
Boris Mailhe
QWQiu Wang
Qiu Wang
JPJosef Pfeuffer
Josef Pfeuffer
MNMariappan S. Nadar
Mariappan S. Nadar

15 October 2018 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
GKGregor Körzdörfer
Gregor Körzdörfer
YJYun Jiang
Yun Jiang
PSPeter Speier
Peter Speier
JPJianing Pang
Jianing Pang
DMDan Ma
Dan Ma
MNMathias Nittka
Mathias Nittka

9 February 2017 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
YCYu‐Zhe Cai
Yu‐Zhe Cai
ZLZhi‐Cheng Li
Zhi‐Cheng Li
PZPan‐Li Zuo
Pan‐Li Zuo
JPJosef Pfeuffer
Josef Pfeuffer
YLYu‐Ming Li
Yu‐Ming Li
RLRong‐Bo Liu
Rong‐Bo Liu